PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests

A joint statement from the Public Health Laboratory Network (PHLN) and Communicable Diseases Network Australia (CDNA) about rapid antigen testing for SARS-CoV-2, the virus that causes coronavirus (COVID-19).

This statement includes: 

  • background
  • limitations of SARS-CoV-2 rapid antigen tests
  • recommendations.

PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests

About this resource

Publication date:
Publication type:
Guideline
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.